Nonapeptide-1

Nonapeptide-1 is a synthetic nine-residue peptide sold under names including Melanostatine and Melanostatine-5. Cosmetics use it for the appearance of dark spots and uneven tone rather than as a bleaching drug or treatment for a pigment disorder.

In pigment-producing melanocytes, alpha-MSH activates the MC1R receptor and increases melanin production. Nonapeptide-1 is designed to compete for that receptor and dampen the downstream enzyme signal. Cell studies use it as a reference alpha-MSH antagonist and show reduced melanin production.

The proposed role is to reduce signals for new pigment rather than strip away existing pigmentation. A brighter, more even-looking complexion remains a cosmetic appearance goal; a cell effect does not establish a visible benefit from a finished product.

It is not an FDA-approved medicine. As an ordinary cosmetic ingredient it does not need drug-style preapproval. Appearance claims are distinct from claims to treat a pigmentation disorder, which would make the product a drug.

Brightening serums and creams use nonapeptide-1 for the look of dark spots, uneven pigmentation and radiance. Formulas may combine it with niacinamide or vitamin C. Daily sun protection is commonly part of the routine because ultraviolet exposure promotes pigmentation.

The available evidence includes a cell study using nonapeptide-1 as a known alpha-MSH blocker. This supports anti-pigment activity in that laboratory setting. Manufacturer brightening claims are not accompanied by an independent peer-reviewed human trial of the ingredient in the available research, so clinical appearance benefit remains unestablished.

Cosmetic reports generally describe low irritation and good tolerability. Independent human safety evidence is limited, however; sensitive users may reasonably patch test rather than assume every formula will be nonirritating.